Detection of gut and mucosal peptides through TOMAHAQ in healthy individuals.
Detection of gut and mucosal peptides through TOMAHAQ in healthy individuals.
复制标题
通过 TOMAHAQ 检测健康个体的肠道和粘膜肽。
作者:
Parsons,ES;Liu,F;Kaushik,A;Lee,A;Schuetz,J;Dunham,D;Seastedt,H;Ogulur,I;Heider,A;Tan,G;Shah,A;Cao,S;Smith,E;Kost,L;Acharya,S;Prunicki,M;Rothenberg,M;Sindher,S;Leib,R;Akdis,CA;Nadeau,K;Lejeune,S
To the Editor, The skin barrier and how to track potential defects in its permeability has been a topic of recent interest. We hypothesized that certain bacterial peptides and peptide fragments of proteins synthetized in skin, lung, and gut cells and secretary tissues draining to the gut should not migrate to other compartments of the body unless a barrier defect is present. Therefore, the presence of peptides from the gastrointestinal tract in blood plasma suggests a functional defect in an individual's respective gut barrier. The epithelial barrier hypothesis suggests that damage to the skin or mucosa via environmental exposures and/or genetic risk factors can result in residual inflammation due to possible translocation of microbiota to the sub-epithelium, which is associated with multiple autoimmune conditions and allergic disorders. 1 The intent of this experiment was to conduct exploratory analysis using targeted mass spectrometry on healthy individuals to test whether gut and mucosal peptides can be detected in plasma, as potential biomarkers which indicate the presence of barrier defects and mucosal leakiness. Using a targeted approach, 115 peptides were selected from the literature (see online supplement for further methods). A subset of 55 regularly detected peptides were quantified using Triggered by Offset, Multiplexed, Accurate mass, High resolution, and Absolute Quantitation (TOMAHAQ)(see online supplement for further methods). 2 A complete list of peptides analyzed is included in Table S2. Data were analyzed from 32 participants (1–22 years) via network analysis (further demographic data is provided in Table S1). Network analysis was conducted to visualize and identify biologically relevant peptides and check for known biological interactions. Thirty-one out of 55 peptides were significantly intercorrelated with high degree of certainty; connections between peptides were defined by a Spearman's correlation coefficient greater than 0.75 and a p-value of> 0.01 (Figure 1A). The top 10 most interconnected peptides were all positively associated with one another (Figure 1B). To further validate, if these peptides were highly interconnected, k-means clustering was applied and the same 31 peptides were conserved. A bacterial peptide (QPVDEIVEYGPTK) was the most interconnected peptide and had the highest degree of connections (S3). QPVDEIVEYGPTK is tryptic peptide from the accumulation-associated protein (AAP) from Staphylococcus epidermidis with no shared homologies with other bacteria. As quantities of QPVDEIVEYGPTK increased so did levels of all other peptides pictured in Figure 1A. QPVDEIVEYGPTK was positively associated with the gastro-intestinal peptide AHVAFPDFFR, a tryptic peptide from sucrase isomaltase (q= 0.0041), which has been previously associated with gut barrier defects (Figure 2A). 3 Additionally, QPVDEIVEYGPTK was positively associated with the plasma protein peptide VQRILGGHLDAK (q= 3* 10− 19) which is derived from both zonulin and haptoglobin. Zonulin has been previously associated with gut permeability as well (Figure 2B). 4 Furthermore, both AHVAFPDFFR (p= 0.00287) and VQRILGGHLDAK (p= 3.52* 10− 06) had positive significant associations with the total number of bacterial peptides detected. QPVDEIVEYGPTK was positively associated with the presence of an IL-33 peptide, DESYEIYVEDLK (p= 1.64* 10− 05), suggesting an association with the alarmin response from the epithelia (Figure 2B). These findings indicate that as levels of QPVDEIVEYGPTK increased in plasma along with gut and mucosal peptides, suggesting that gut permeability increases with peptides from AAP from S …